Overview
Bacterial vaginosis (BV) is a common condition characterized by alterations in vaginal flora, leading to an overgrowth of anaerobic bacteria and decreased lactobacilli, often without significant symptoms but associated with increased risks of adverse pregnancy outcomes and gynecological infections 4.Diagnosis
Key Diagnostic Criteria: Presence of three of the following four Amsel criteria: homogeneous vaginal discharge, positive whiff test, clue cells on microscopy, and vaginal pH > 4.5 1.
Recommended Tests: Gram stain (Nugent scoring system) for definitive diagnosis 4.
Grading: Nugent score categorizes vaginal flora as normal, intermediate, or BV 4.Management
First-Line Treatment: Oral metronidazole (typically 500 mg twice daily for 7 days) or tinidazole (2 g as a single dose) 4.
Adjunctive Treatments: High-dose vitamin D supplementation (9 doses of 50,000 IU cholecalciferol over 24 weeks) may reduce recurrence rates, though evidence is preliminary 3.
Probiotics: Limited evidence suggests potential benefits in BV management, but quality and efficacy vary 5.Special Populations
Pregnancy: Screening and treatment of BV in pregnancy are recommended to reduce risks of preterm labor and premature rupture of membranes 4.
Vitamin D Status: Lower levels of 25-hydroxy vitamin D are associated with BV in pregnant African American women, suggesting potential for targeted supplementation 2.Key Recommendations
Screen and treat pregnant women for BV to mitigate risks of adverse pregnancy outcomes such as preterm birth (Evidence: Strong 4).
Consider baseline vitamin D status in pregnant women, particularly African American women, as lower levels correlate with BV (Evidence: Moderate 2).
High-dose vitamin D supplementation may be explored as an adjunct to standard antibiotic therapy to reduce BV recurrence, though further research is needed (Evidence: Weak 3).
Probiotics may have a role in BV management, but their efficacy varies; current evidence is insufficient for definitive recommendations (Evidence: Weak 5).References
1 Mojtahedi SF, Mohammadzadeh A, Mohammadzadeh F, Jalili Shahri J, Bahri N. Association between bacterial vaginosis and 25-Hydroxy vitamin D: a case-control study. BMC infectious diseases 2023. link
2 Dunlop AL, Jordan SL, Ferranti EP, Hill CC, Patel S, Hao L et al.. Total and Free 25-Hydroxy-Vitamin D and Bacterial Vaginosis in Pregnant African American Women. Infectious diseases in obstetrics and gynecology 2019. link
3 Turner AN, Carr Reese P, Fields KS, Anderson J, Ervin M, Davis JA et al.. A blinded, randomized controlled trial of high-dose vitamin D supplementation to reduce recurrence of bacterial vaginosis. American journal of obstetrics and gynecology 2014. link
4 Yudin MH, Money DM. Screening and management of bacterial vaginosis in pregnancy. Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC 2008. link32919-X)
5 Reid G, Kirjaivanen P. Taking probiotics during pregnancy. Are they useful therapy for mothers and newborns?. Canadian family physician Medecin de famille canadien 2005. link